The global buprenorphine transdermal patches market is anticipated to grow at a significant CAGR 3.8% during the forecast period (2022-2028). Buprenorphine patches are used as a pain reliever and belongs to a class of medications called opiate (narcotic) analgesics. They support to relieve severe pain in people who need pain medication around the clock for a long time and that cannot be treated with other medications. The major factor driving the demand for the global buprenorphine transdermal patches market is the increasing demand and application as a pain reliever across the globe. 

Moreover, these patches are marketed as a Schedule III medicine. It is used for the management of pain severe enough to require daily, around-the-clock and for long-term opioid treatment. Additionally, the market is also growing owing to the improvement in inpatient drug delivery during the forecast period. However, the growth of the market is hampered due to several side effects related to these patches. 

Some major players in the market include Grunenthal, PurduePharma, Luye Pharma, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in April 2020, Amneal Pharmaceuticals announced the approval of Abbreviated New Drug Application (ANDA) for a generic version of Butrans (buprenorphine) Transdermal System from the US Food and Drug Administration (FDA). The company received the approval for Butrans in 5 mcg/hr, 7.5 mcg/hr, 10 mcg/hr, 15 mcg/hr and 20 mcg/hr. Additionally, the company was also granted the Competitive Generic Therapy (CGT) designation and 180 days of exclusivity for the 7.5 mcg/hr dose.

Market Coverage

• The market number available for – 2021-2028

• Base year- 2021

• Forecast period- 2022-2028

• Segment Covered- 

o By Type

o By Application

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- Grunenthal, Luye Pharma, and Amneal Pharmaceuticals, among others. 

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How players are addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Buprenorphine Transdermal Patches Market Report by Segment

By Type

• 5mcg/h

• 7.5mcg/h

• 10mcg/h

• 15 mcg/h

• 20 mcg/h

By Application 

• Cancer Pain

• Others

Global Buprenorphine Transdermal Patches Market Report by Region

North America

• United States

• Canada

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa